ASCO 2026 Data Demonstrate Long-term Survival Benefit of Plinabulin/Docetaxel and Pembrolizumab in Metastatic NSCLC Following Progression on ...
On Track to Complete Enrollment of Phase 3 ELAINE-3 Clinical Trial of Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic ...
Parabilis Medicines is rated a Buy; it leverages rare, genetically simple tumors to validate its Helicon platform. Read more ...
KNOXVILLE, Tenn.-- (BUSINESS WIRE)--Aug 14, 2026-- ...
‘We’re not afraid of competition’: BioCryst CEO sets out strategy after scrapping internal discovery
BioCryst CEO Charlie Gayer told Fierce the company is “not getting away from science and R&D” despite shutting down its ...
Seattle biotech InduPro has raised $77 million and dosed its first patient in a Phase 1 trial of an experimental cancer drug, ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company leveraging a deep understanding of nose-to-brain neurocircuitry to develop and commercialize a new class of rapid-onset ...
A prime example unfolded when Royalty Pharma plc (NASDAQ:RPRX) acquired a portion of Neurimmune’s royalty interest in ...
Roche's Q2 results show 5% revenue growth, margin upside and key pipeline catalysts ahead. Click to read my analysis.
At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Q2 2026 Investor Update Conference Call. [Operator Instructions] I would like to now turn the call over to Chris Stamm, ...
JW Pharmaceutical (KRX:001060) announced that the multinational Phase 3 clinical trial of its gout treatment candidate ...
It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results